{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for clindamycin root_notes_note in Note (approximate match)
Status:
Possibly Marketed Outside US
Source:
M020
(2022)
Source URL:
First approved in 2022
Source:
M020
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2023)
Source URL:
First approved in 2021
Source:
M032
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M021
(2019)
Source URL:
First approved in 2019
Source:
M021
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2016)
Source URL:
First approved in 2016
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2015)
Source URL:
First approved in 2015
Source:
21 CFR 348
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2013)
Source URL:
First approved in 2013
Source:
21 CFR 333D
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NDA217242
(2011)
Source URL:
First approved in 2011
Source:
NDA217242
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA065488
(1991)
Source URL:
First approved in 1989
Source:
21 CFR 343
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
First approved in 1983
Source:
NADA125961
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
JAN:CYTOCHROME C [JAN]
Source URL:
Class:
PROTEIN
